Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Sales | 711 | 512 | 493 | 642 | 783 |
| Gross Profit | 720 | 710 | 500 | 660 | 770 |
| Operating Expenses | 4,670 | 4,850 | 3,880 | 4,570 | 4,010 |
| Operating Income | -3,959 | -4,338 | -3,387 | -3,928 | -3,227 |
| Interest Expense | 2 | -2 | 5 | 2 | 5 |
| Other Income | 271 | -294 | 112 | -150 | 352 |
| Pre-tax Income | -3,690 | -4,630 | -3,280 | -4,080 | -2,880 |
| Income Tax | 10 | -202 | 10 | 0 | 2 |
| Net Income Continuous | -3,657 | -3,520 | -3,232 | -3,961 | -2,926 |
| Net Income | $-3,657 | $-3,520 | $-3,232 | $-3,961 | $-2,926 |
| EPS Basic Total Ops | -1.80 | -2.16 | -2.16 | -2.52 | -1.80 |
| EPS Basic Continuous Ops | -1.81 | -2.03 | -1.97 | -2.50 | -1.95 |
| EPS Diluted Total Ops | -1.80 | -2.16 | -2.16 | -2.52 | -1.80 |
| EPS Diluted Continuous Ops | -1.81 | -2.03 | -1.97 | -2.50 | -1.95 |
| EBITDA(a) | $-4,069 | $-4,078 | $-3,387 | $-3,918 | $-3,157 |